AMC Annual Report 2018
2018 Pneumococcal AMC Annual Report
The 2018 Pneumococcal AMC Annual Report gives an overview of the activities linked to the implementation of the pilot Advance Market Commitment from 1 January to 31 December 2018.
It was developed by the AMC Secretariat at Gavi, in collaboration with the World Bank and UNICEF’s Supply Division.
View previous Annual Reports: 2017 | 2016 | 2015 | 2014-2015 | 2013-2014 | 2012-2013 | 2011-2012 | 2010-2011 | 2009-2010
AMC donor logos
If you represent a vaccine manufacturer and are interested in participating in the pneumococcal AMC, this section explains how to make your offer.
Suppliers must sign a registration agreement relating to the AMC terms and conditions.
UNICEF issues Calls for Supply Offers following the publication of the Strategic Demand Forecast.
UNICEF pre-tender meeting
UNICEF call for supply offers
Remaining AMC offer amount
LATEST GAVI UPDATES ON THE GLOBAL ROLLOUT OF PNEUMOCOCCAL VACCINE
Close to 1 million Myanmar children to be protected
Bangladesh introduces pneumococcal vaccine
Niger tackles its two biggest child killers
Innovative mechanism makes vaccines available for children in developing countries at the right price, in the right quantity and at the right time.
How the pneumococcal AMC works
Step by step guide to the method behind the AMC mechanism linking donors, the World Bank, WHO, UNICEF and developing country governments.
Gavi Vietnam Jeff Holt 1041
Gavi-eligible countries should apply for Gavi pneumococcal vaccine support in the usual way. Countries that are in transition or no longer eligible for other forms of Gavi support, should follow separate application guidelines.